Group One Trading
ANTH

Group One Trading’s Anthera Pharmaceuticals, Inc. ANTH Stock Holding History

Group One Trading’s Portfolio ANTH Stock Details ANTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-2,361
Closed -$1K – 5770
2018
Q1 		$1K Buy
+2,361
New +$3.52K ﹤0.01% 4743
2017
Q4 		– Sell
-3,580
Closed -$6.16K – 5543
2017
Q3 		$5K Buy
+3,580
New +$5.09K ﹤0.01% 4517
2017
Q2 		– Sell
-19,383
Closed -$43.5K – 5365
2017
Q1 		$66K Buy
19,383
+9,251
+91% +$43.7K ﹤0.01% 3242
2016
Q4 		$53K Buy
10,132
+6,239
+160% +$108K ﹤0.01% 3237
2016
Q3 		$98K Buy
+3,893
New +$98.2K ﹤0.01% 2939
2016
Q1 		– Sell
-8,192
Closed -$222K – 5273
2015
Q4 		$304K Sell
8,192
-68
-0.8% -$3K ﹤0.01% 2197
2015
Q3 		$402K Buy
8,260
+6,819
+473% +$476K 0.01% 1953
2015
Q2 		$99K Buy
+1,441
New +$66.7K ﹤0.01% 3103
2014
Q4 		– Sell
-938
Closed -$13.6K – 5545
2014
Q3 		$14K Sell
938
-268
-22% -$5.64K ﹤0.01% 4320
2014
Q2 		$33K Buy
1,206
+1,168
+3,074% +$28.8K ﹤0.01% 3835
2014
Q1 		$1K Buy
+38
New +$965 ﹤0.01% 5094

Other funds holding ANTH

WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

Group One Trading's ANTH Position: Q2 2018 in Review

Group One Trading sold out of Anthera Pharmaceuticals, Inc. (ANTH) in Q2 2018, closing a stake of 2,361 shares — an estimated $1K sold.

Group One Trading first reported a position in ANTH in Q1 2014 and held it in 11 quarters. The position peaked at $402K in Q3 2015. 5 funds tracked by Wall St. Rank hold ANTH as of Q2 2018.

  • Group One Trading reported no remaining Anthera Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • Group One Trading sold 2,361 Anthera Pharmaceuticals, Inc. shares in Q2 2018, an estimated $1K.
  • Group One Trading first reported a position in Anthera Pharmaceuticals, Inc. in Q1 2014 and held it in 11 quarters.
  • Group One Trading's Anthera Pharmaceuticals, Inc. position peaked at $402K in Q3 2015.
  • 5 funds tracked by Wall St. Rank held Anthera Pharmaceuticals, Inc. as of Q2 2018.

Based on Group One Trading's 13F filing for Q2 2018, filed 14 Aug 2018.